Pdt Partners, LLC Harrow Health, Inc. Transaction History

Pdt Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.75 - $7.74 $70,069 - $94,319	-12,186 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.77 - $8.66 $34,906 - $44,650	-5,156 Reduced 29.73%	12,186 $83,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $75,650 - $106,800	-8,900 Reduced 33.92%	17,342 $150,000
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $12,875 - $19,525	1,842 Added 7.55%	26,242 $239,000
Q2 2021 Aug 16, 2021	SELL	$6.68 - $11.07 $14,408 - $23,877	-2,157 Reduced 8.12%	24,400 $227,000

Q1 2021 May 17, 2021	BUY	$6.26 - $11.03 $15,036 - $26,494	2,402 Added 9.94%	26,557 $179,000
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $36,176 - $52,668	7,600 Added 45.91%	24,155 $166,000
Q3 2020 Nov 16, 2020	BUY	$4.71 - $7.36 $77,974 - $121,844	16,555 New	16,555 $93,000

123

21.3M

113K

366K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $565M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.